Uni-Bio Science Group Limited Announces Extraordinary General Meeting and Major Share Option Grants
Uni-Bio Science Group Limited (“the Company”, Stock Code: 0690) has issued a notice for an Extraordinary General Meeting (EGM) to be held at 10:30 a.m. on Wednesday, 19 August 2026, at its Hong Kong Science Park headquarters. This EGM represents a pivotal event for shareholders, with several resolutions proposed that may significantly impact the Company’s future direction and share value.
Key Points and Resolutions
- Major Share Option Grants: The Company’s board will seek shareholder approval for the conditional grant of share options to key executives, totaling 300,000,000 new shares at an exercise price of HK\$0.09 per share. These grants are part of the Share Option Scheme adopted at the general meeting on 26 May 2026.
- Recipients of Share Options:
- Mr. Leung Kingsley (Chairman and Executive Director): 90,000,000 options
- Mr. Zhao Zhi Gang (Chief Executive Officer): 90,000,000 options
- Dr. Wen Yalei (Chief Operating Officer): 60,000,000 options
- Mr. Cheng Yu-Jen (Chief Business Officer): 60,000,000 options
- Terms and Conditions: Each option entitles the holder to subscribe for new shares at HK\$0.09 per share, as detailed in the Company’s circular dated 30 July 2026. The options are conditional on shareholder approval at the EGM.
Potential Price Sensitivity and Shareholder Considerations
- Share Dilution Risk: If exercised in full, these options would result in the issuance of 300 million new shares, which could lead to significant share dilution. This may affect the share price, especially given the exercise price of HK\$0.09 per share, which could be below the prevailing market price.
- Executive Incentives: The substantial allocation of options to senior management aligns their interests with shareholders but may also raise concerns about governance and the scale of equity compensation.
- Timing and Voting: The register of members will be closed from 14 August to 19 August 2026. Only shareholders registered by 13 August 2026 will be eligible to attend and vote. Proxy forms must be submitted by 10:30 a.m. on 17 August 2026.
- Poll Voting: All resolutions at the EGM will be decided by poll, ensuring transparency in the voting process.
Board Composition
The current board consists of four executive directors (Mr. Leung Kingsley, Mr. Chen Dawei, Mr. Zhao Zhi Gang, Dr. Wen Yalei), two non-executive directors (Mr. Yau Kwok Wing Tony, Ms. Zhang Qing), and three independent non-executive directors (Mr. Chow Kai Ming, Mr. Ren Qimin, Mr. Ma Qingshan).
Implications for Investors
The proposed share option grants are a significant move and could materially impact the Company’s capital structure and share price. Investors should carefully assess the potential dilution and the alignment of management interests before voting.
Other Information
The notice will remain available on the Stock Exchange’s website and the Company’s website for at least seven days from publication. All information provided is confirmed to be accurate and complete by the Company’s directors.
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Investors should seek independent professional advice before making investment decisions. The author and publisher accept no liability for any losses arising from reliance on this information.
